Skip to Content

Impedimed Ltd IPDQF

Morningstar Rating
$0.07 0.00 (7.55%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

IPDQF is trading at a 625% premium.
Price
$0.07
Fair Value
$9.80
Uncertainty
Extreme
1-Star Price
$7.87
5-Star Price
$3.52
Economic Moat
Bpfpf
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if IPDQF is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.06
Day Range
$0.070.07
52-Week Range
$0.040.15
Bid/Ask
$0.04 / $0.06
Market Cap
$138.38 Mil
Volume/Avg
930 / 25,149

Key Statistics

Price/Earnings (Normalized)
Price/Sales
22.50
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Impedimed Ltd, together with its subsidiaries, operates in the medical devices space. The company is based in Australia and operates globally, and it generates most of its revenue in North America. It is engaged in developing, manufacturing, and distributing noninvasive medical devices. The company offers products that are typically used to assess and monitor lymphedema and heart failure, as well as to measure the tissue composition and fluid status of the patients. The company also offers a cloud-based digital platform (branded as SOZO) to manage patient data. The Company recognizes revenue from stand alone sale of Legacy Devices and Consumables, Sale of SOZO Device and Software Subscription Services.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Core
Total Number of Employees
73

Comparables

Valuation

Metric
IPDQF
AMBU B
002901
Price/Earnings (Normalized)
93.14729.57
Price/Book Value
3.986.293.37
Price/Sales
22.507.046.79
Price/Cash Flow
44.1746.75
Price/Earnings
IPDQF
AMBU B
002901

Financial Strength

Metric
IPDQF
AMBU B
002901
Quick Ratio
6.601.381.71
Current Ratio
7.002.532.88
Interest Coverage
34.009.27
Quick Ratio
IPDQF
AMBU B
002901

Profitability

Metric
IPDQF
AMBU B
002901
Return on Assets (Normalized)
5.47%0.29%
Return on Equity (Normalized)
7.03%0.41%
Return on Invested Capital (Normalized)
6.30%−0.13%
Return on Assets
IPDQF
AMBU B
002901
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
XnqkskgzcJnmrch$182.1 Bil
Stryker Corp
SYK
ZzzffmgjpZqsqb$127.5 Bil
Boston Scientific Corp
BSX
YxldzlfssNnmjbc$113.8 Bil
Medtronic PLC
MDT
KsvxqzhmmVvsfy$104.2 Bil
Edwards Lifesciences Corp
EW
PjqhdjdhfBnsyd$52.6 Bil
DexCom Inc
DXCM
PbvcjxrxrtMvsy$45.4 Bil
Koninklijke Philips NV ADR
PHG
BxkbntbwKwsfqvg$24.2 Bil
Zimmer Biomet Holdings Inc
ZBH
YrqxvvrlvLsv$22.8 Bil
Steris PLC
STE
TswqnqbjHddvp$22.6 Bil
Align Technology Inc
ALGN
DmxbztzFywql$18.9 Bil

Sponsor Center